corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 621

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Horton R.
Prizes, publications, and promotion.
Lancet 1996 Nov 23; 348:(9039):1398


Abstract:

Janssen-Cilag was this year’s winner of the Prix Galien, given for innovation and development in pharmaceutical research and development, for its antipsychotic drug, risperidone. In an effort to complete a meta-analysis of risperidone trials, two researchers found evidence of redundant publications, slippery authorship and opaque reporting of trial data. The effect of this extraordinary publication activity was a greatly enhanced visibility for risperidone at at critical time in the drug’s history.

Keywords:
*analysis publication bias Janssen risperidone INFLUENCE OF PROMOTION: PUBLICATION PROMOTION DISGUISED: CLINICAL TRIALS PROMOTION DISGUISED: GHOST-WRITING AND JOURNAL ARTICLES SPONSORSHIP: RESEARCH

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend